Recce Pharmaceuticals Doses First Participants in Next
First participants (male/female) dosed at 4,000mg over 20 minutes, with remaining subjects to be dosed in the near future - ...
Read moreFirst participants (male/female) dosed at 4,000mg over 20 minutes, with remaining subjects to be dosed in the near future - ...
Read morePARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in Munich and ...
Read moreFirst patient dosed in Australia where 3 clinical trial sites have been activated.The trial will enrol advanced colorectal cancer patients ...
Read moreStudy to assess efficacy and safety of CVN424 as a monotherapy in early-stage Parkinson’s disease BOSTON, Nov. 13, 2023 (GLOBE ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.